688139 海尔生物
已收盘 07-03 15:00:00
资讯
新帖
简况
股市必读：海尔生物（688139）7月2日董秘有最新回复
证券之星 · 04:25
股市必读：海尔生物（688139）7月2日董秘有最新回复
海尔生物获得实用新型专利授权：“样本存储库”
证券之星 · 03:24
海尔生物获得实用新型专利授权：“样本存储库”
海尔生物(688139.SH)拟5000万元至1亿元回购公司股份
智通财经 · 07-02 16:42
海尔生物(688139.SH)拟5000万元至1亿元回购公司股份
股市必读：海尔生物(688139)股东户数1.44万户，较上期增加0.77%
证券之星 · 07-02 03:54
股市必读：海尔生物(688139)股东户数1.44万户，较上期增加0.77%
海尔生物：产品方案应用于药物研发、小试、中试、质控等环节
证券之星 · 07-01 16:00
海尔生物：产品方案应用于药物研发、小试、中试、质控等环节
海尔生物：第二季度公司利润预计同比大幅增长
证券之星 · 07-01 16:00
海尔生物：第二季度公司利润预计同比大幅增长
海尔生物：截至2026年6月30日，公司股东总数为14,379户
证券之星 · 07-01 16:00
海尔生物：截至2026年6月30日，公司股东总数为14,379户
每周股票复盘：海尔生物（688139）股东户数增2.26%至1.43万户
证券之星 · 06-28
每周股票复盘：海尔生物（688139）股东户数增2.26%至1.43万户
海尔生物(688139.SH)控股股东提议以5000万元至1亿元回购公司股份
智通财经 · 06-25
海尔生物(688139.SH)控股股东提议以5000万元至1亿元回购公司股份
海尔生物：控股股东提议公司5000万元—1亿元回购股份
格隆汇 · 06-25
海尔生物：控股股东提议公司5000万元—1亿元回购股份
海尔生物（688139）披露控股子公司增资扩股及放弃优先认购权暨关联交易议案获通过，6月22日股价下跌1.61%
证券之星 · 06-22
海尔生物（688139）披露控股子公司增资扩股及放弃优先认购权暨关联交易议案获通过，6月22日股价下跌1.61%
海尔生物(688139)6月18日股东户数1.43万户，较上期增加2.26%
证券之星 · 06-22
海尔生物(688139)6月18日股东户数1.43万户，较上期增加2.26%
海尔生物：截至2026年6月18日，公司股东总数为14,269户
证券之星 · 06-22
海尔生物：截至2026年6月18日，公司股东总数为14,269户
每周股票复盘：XD海尔生（688139）鸿鹄航空拟增资扩股引入新投资者
证券之星 · 06-20
每周股票复盘：XD海尔生（688139）鸿鹄航空拟增资扩股引入新投资者
股市必读：海尔生物（688139）6月16日董秘有最新回复
证券之星 · 06-17
股市必读：海尔生物（688139）6月16日董秘有最新回复
海尔生物（688139）披露控股子公司增资扩股暨关联交易公告，6月16日股价上涨0.07%
证券之星 · 06-16
海尔生物（688139）披露控股子公司增资扩股暨关联交易公告，6月16日股价上涨0.07%
海尔生物：公司超速离心机于今年上市
证券之星 · 06-16
海尔生物：公司超速离心机于今年上市
海尔生物：公司实控人的一致行动人青岛海创智管理咨询企业（有限合伙）已三次增持公司股票
证券之星 · 06-16
海尔生物：公司实控人的一致行动人青岛海创智管理咨询企业（有限合伙）已三次增持公司股票
每周股票复盘：海尔生物（688139）股东户数降6.61%，海外重点国家收入增超30%
证券之星 · 06-14
每周股票复盘：海尔生物（688139）股东户数降6.61%，海外重点国家收入增超30%
海尔生物：第二季度公司利润预计同比大幅增长
证券之星 · 06-10
海尔生物：第二季度公司利润预计同比大幅增长
加载更多
公司概况
公司名称：
青岛海尔生物医疗股份有限公司
所属行业：
专用设备制造业
上市日期：
2019-10-25
主营业务：
青岛海尔生物医疗股份有限公司的主营业务是针对样本、药品、疫苗、血液等生物对象，提供涵盖-196°C至8°C全温域、软硬服一体化的生物安全解决方案。公司的主要产品是智慧实验室制药工艺、数字医院、智慧公共卫生、智慧用血。报告期内，公司低温存储技术持续领先，依托制冷平台，通过持续优化制冷系统设计、温湿控制和节能技术等核心模块，在极致稳定、绿色效能方向上构筑起代际领先优势。
发行价格：
15.53
{"stockData":{"symbol":"688139","market":"SH","secType":"STK","nameCN":"海尔生物","latestPrice":27.63,"timestamp":1783062000000,"preClose":26.83,"halted":0,"volume":4507913,"delay":0,"changeRate":0.0298,"floatShares":316000000,"shares":316000000,"eps":0.695,"marketStatus":"已收盘","change":0.8,"latestTime":"07-03 15:00:00","open":27.28,"high":28.08,"low":27.11,"amount":124000000,"amplitude":0.0362,"askPrice":27.63,"askSize":14,"bidPrice":27.62,"bidSize":40,"shortable":0,"etf":0,"ttmEps":0.695,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":5,"adr":0,"adjPreClose":26.83,"symbolType":"stock_kcb","openAndCloseTimeList":[[1783042200000,1783049400000],[1783054800000,1783062000000]],"highLimit":29.51,"lowLimit":24.15,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":316492922,"isCdr":false,"pbRate":1.96,"roa":"--","peRate":39.755396,"roe":"1.8%","epsLYR":0.8,"committee":-0.607908,"marketValue":8745000000,"turnoverRate":0.0142,"status":0,"afterMarket":{"amount":0,"volume":0,"close":27.63,"buyVolume":0,"sellVolume":85275,"time":1783064037746,"indexStatus":"已收盘 07-03 15:30:00","preClose":26.83},"floatMarketCap":8745000000},"requestUrl":"/m/hq/s/688139","defaultTab":"news","newsList":[{"id":"2648633838","title":"股市必读：海尔生物（688139）7月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648633838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648633838?lang=zh_cn&edition=full","pubTime":"2026-07-03 04:25","pubTimestamp":1783023912,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，海尔生物报收于26.83元，上涨0.07%，换手率1.29%，成交量4.08万手，成交额1.1亿元。公司公告汇总海尔生物第三届董事会第十三次会议决议公告青岛海尔生物医疗股份有限公司于2026年7月2日召开第三届董事会第十三次会议，审议通过《关于以集中竞价交易方式回购公司股份方案的议案》和《关于提请召开2026年第二次临时股东会的议案》。股东会定于2026年7月20日以现场加网络投票方式召开。相关股东未来3至6个月暂无减持计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300005363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648680621","title":"海尔生物获得实用新型专利授权：“样本存储库”","url":"https://stock-news.laohu8.com/highlight/detail?id=2648680621","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648680621?lang=zh_cn&edition=full","pubTime":"2026-07-03 03:24","pubTimestamp":1783020279,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示海尔生物新获得一项实用新型专利授权，专利名为“样本存储库”，专利申请号为CN202521363031.3，授权日为2026年7月3日。今年以来海尔生物新获得专利授权53个，较去年同期增加了43.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300003754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648084885","title":"海尔生物(688139.SH)拟5000万元至1亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2648084885","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648084885?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:42","pubTimestamp":1782981766,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海尔生物(688139.SH)发布公告，公司拟使用自有资金通过集中竞价交易方式进行股份回购，回购的股份拟全部用于减少注册资本。回购资金总额不低于5000万元(含)，不超过1亿元(含)。回购股份价格不超过46元/股(含)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462302.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648903525","title":"股市必读：海尔生物(688139)股东户数1.44万户，较上期增加0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648903525","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648903525?lang=zh_cn&edition=full","pubTime":"2026-07-02 03:54","pubTimestamp":1782935651,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，海尔生物报收于26.81元，上涨1.48%，换手率1.29%，成交量4.1万手，成交额1.09亿元。股本股东变化：截至2026年6月30日，海尔生物股东户数为1.44万户，较6月18日增长0.77%。股本股东变化股东户数变动截至2026年6月30日公司股东户数为1.44万户，较6月18日增加110.0户，增幅为0.77%；户均持股数量由2.22万股减少至2.2万股，户均持股市值为58.15万元。董秘： 尊敬的投资者您好，截至2026年6月30日，公司股东总数为14,379户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200001819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648515891","title":"海尔生物：产品方案应用于药物研发、小试、中试、质控等环节","url":"https://stock-news.laohu8.com/highlight/detail?id=2648515891","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648515891?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:00","pubTimestamp":1782892853,"startTime":"0","endTime":"0","summary":"证券之星消息，海尔生物07月01日在投资者关系平台上答复投资者关心的问题。当前，公司正围绕制药应用场景，持续拓展产品组合与解决方案，以更好满足快速发展的用户需求。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100028255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648862515","title":"海尔生物：第二季度公司利润预计同比大幅增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2648862515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648862515?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:00","pubTimestamp":1782892852,"startTime":"0","endTime":"0","summary":"证券之星消息，海尔生物07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：公司既然对2026年二季度业绩非常有信心，为什么不发布业绩预告？收入端，预计自第二季度起收入增速将出现明显提速，全年回归上、下半年收入“前低后高”的发展态势；盈利端，第二季度公司利润预计同比大幅增长，带动上半年利润端出现拐点，下半年利润增幅预计将明显高于上半年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100028252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648515895","title":"海尔生物：截至2026年6月30日，公司股东总数为14,379户","url":"https://stock-news.laohu8.com/highlight/detail?id=2648515895","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648515895?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:00","pubTimestamp":1782892852,"startTime":"0","endTime":"0","summary":"证券之星消息，海尔生物(688139)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至6月底股东人数是多少，谢谢！海尔生物回复：尊敬的投资者您好，截至2026年6月30日，公司股东总数为14,379户。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100028251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646313173","title":"每周股票复盘：海尔生物（688139）股东户数增2.26%至1.43万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2646313173","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646313173?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:30","pubTimestamp":1782585034,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，海尔生物报收于24.7元，较上周的26.67元下跌7.39%。本周，海尔生物6月23日盘中最高价报27.56元。本周关注点股本股东变化：股东户数较6月10日增加316.0户，增幅为2.26%，达1.43万户。户均持股数量由上期的2.27万股减少至2.22万股，户均持股市值为59.16万元。普通股股东共128人出席，代表表决权32.4392%。议案1获通过，同意票占98.4365%，其中中小投资者同意票占比95.4223%。表决结果为同意98.4365%，反对1.4711%，弃权0.0924%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646879252","title":"海尔生物(688139.SH)控股股东提议以5000万元至1亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2646879252","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646879252?lang=zh_cn&edition=full","pubTime":"2026-06-25 18:00","pubTimestamp":1782381657,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海尔生物(688139.SH)发布公告，2026年6月25日，公司收到公司控股股东青岛海尔生物医疗控股有限公司《关于提议青岛海尔生物医疗股份有限公司回购公司股份的函》。海尔生物医疗控股提议公司以自有资金通过上海证券交易所交易系统以集中竞价交易方式回购公司已发行的部分人民币普通股(A股)股票，回购股份的资金总额不低于5000万元(含)，不超过1亿元(含)，具体以董事会审议通过的回购股份方案为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1458767.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646879956","title":"海尔生物：控股股东提议公司5000万元—1亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2646879956","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646879956?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:59","pubTimestamp":1782381562,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645964073","title":"海尔生物（688139）披露控股子公司增资扩股及放弃优先认购权暨关联交易议案获通过，6月22日股价下跌1.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645964073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645964073?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:32","pubTimestamp":1782138741,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，海尔生物报收于26.24元，较前一交易日下跌1.61%，最新总市值为83.05亿元。公告显示，公司于2026年6月22日召开2026年第一次临时股东会，审议通过了《关于控股子公司增资扩股及公司放弃优先认购权暨关联交易的议案》。普通股股东共128人出席，代表表决权32.4392%。议案获同意票占98.4365%，其中中小投资者同意票占比95.4223%。关联方青岛海尔生物医疗控股有限公司等回避表决。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645234480","title":"海尔生物(688139)6月18日股东户数1.43万户，较上期增加2.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645234480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645234480?lang=zh_cn&edition=full","pubTime":"2026-06-22 17:40","pubTimestamp":1782121222,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海尔生物披露，截至2026年6月18日公司股东户数为1.43万户，较6月10日增加316.0户，增幅为2.26%。在医疗器械行业个股中，海尔生物股东户数低于行业平均水平，截至6月18日，医疗器械行业平均股东户数为2.21万户。从股价来看，2026年6月10日至2026年6月18日，海尔生物区间涨幅为1.2%，在此期间股东户数增加316.0户，增幅为2.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200026289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645044212","title":"海尔生物：截至2026年6月18日，公司股东总数为14,269户","url":"https://stock-news.laohu8.com/highlight/detail?id=2645044212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645044212?lang=zh_cn&edition=full","pubTime":"2026-06-22 15:36","pubTimestamp":1782113788,"startTime":"0","endTime":"0","summary":"证券之星消息，海尔生物(688139)06月22日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问公司6月20日的股东人数是多少？谢谢！海尔生物回复：尊敬的投资者您好，截至2026年6月18日，公司股东总数为14,269户。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200016602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644065565","title":"每周股票复盘：XD海尔生（688139）鸿鹄航空拟增资扩股引入新投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2644065565","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644065565?lang=zh_cn&edition=full","pubTime":"2026-06-20 02:51","pubTimestamp":1781895069,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，XD海尔生报收于26.67元，较上周的27.07元下跌1.48%。本周，XD海尔生6月16日盘中最高价报27.36元。XD海尔生当前最新总市值84.41亿元，在医疗器械板块市值排名35/129，在两市A股市值排名2234/5206。本周关注点公司公告汇总：鸿鹄航空拟增资扩股，引入安徽徽海启明创业投资基金和兰溪聚创创业投资作为投资方。增资完成后，鸿鹄航空注册资本由3,750万元增至4,625万元，公司持股比例由72%降至58.38%，鸿鹄航空仍为公司控股子公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000000898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159231","BK1617","02252","BK1100","LU2488822045.USD","01169","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644776098","title":"股市必读：海尔生物（688139）6月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644776098","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644776098?lang=zh_cn&edition=full","pubTime":"2026-06-17 04:28","pubTimestamp":1781641693,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，海尔生物报收于27.1元，上涨0.07%，换手率1.03%，成交量3.27万手，成交额8753.46万元。公司公告汇总：海尔生物控股子公司鸿鹄航空拟增资扩股，引入两家关联方投资共7,000万元，公司放弃优先认购权，持股比例由72%降至58.38%，仍保持控股地位；该关联交易需提交股东会审议。因投资方与公司同受海尔集团公司控制，本次交易构成关联交易，需提交股东会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700003748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643598737","title":"海尔生物（688139）披露控股子公司增资扩股暨关联交易公告，6月16日股价上涨0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643598737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643598737?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:45","pubTimestamp":1781606716,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，海尔生物报收于27.1元，较前一交易日上涨0.07%，最新总市值为85.77亿元。该股当日开盘27.01元，最高27.36元，最低26.33元，成交额达8753.46万元，换手率为1.03%。海尔生物放弃本次增资的优先认购权。增资完成后，鸿鹄航空注册资本由3,750万元增至4,625万元，公司持股比例由72%降至58.38%，鸿鹄航空仍为公司控股子公司。因投资方与公司同受海尔集团公司控制，本次交易构成关联交易，需提交股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600036539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643755009","title":"海尔生物：公司超速离心机于今年上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2643755009","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643755009?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:21","pubTimestamp":1781605303,"startTime":"0","endTime":"0","summary":"证券之星消息，海尔生物(688139)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司研发的国内首台10万转离心机销售情况如何？海尔生物回复：尊敬的投资者您好，作为分离、纯化和分析病毒、蛋白质、核酸、外泌体等生物大分子或亚细胞结构的关键设备，公司超速离心机于今年上市，目前处于市场导入期，已经有多家生物科技企业、研究所等用户订单录入，预计自明年起逐渐进入规模化放量阶段。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600033695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643675570","title":"海尔生物：公司实控人的一致行动人青岛海创智管理咨询企业（有限合伙）已三次增持公司股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2643675570","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643675570?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:21","pubTimestamp":1781605302,"startTime":"0","endTime":"0","summary":"另一方面，运用现金分红、投资者关系管理、信息披露、股份回购等各种方式，提升公司的投资价值和股东回报能力，自上市以来，公司已连续7年实施分红，累计分红8.91亿元人民币，其中2025年年度现金分红将于6月18日发放；公司实控人的一致行动人青岛海创智管理咨询企业已三次增持公司股票，累计增持金额约3.84亿元；公司自身共推出了三轮股份回购计划，累计回购金额共计约2.5亿元，并于2026年1月6日注销部分已回购股份145.96万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600033693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643217906","title":"每周股票复盘：海尔生物（688139）股东户数降6.61%，海外重点国家收入增超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643217906","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643217906?lang=zh_cn&edition=full","pubTime":"2026-06-14 01:26","pubTimestamp":1781371572,"startTime":"0","endTime":"0","summary":"截至2026年6月12日收盘，海尔生物报收于27.07元，较上周的29.82元下跌9.22%。本周，海尔生物6月8日盘中最高价报30.19元。来自机构调研要点：2026年一季度，公司锁定的24个重点国家合计收入增幅超30%。股本股东变化截至2026年6月10日，公司股东户数为1.4万户，较5月31日减少988户，减幅6.61%。户均持股数量由上期的2.12万股升至2.27万股，户均持股市值为60.52万元。相关进展将依规履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061400000244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642144480","title":"海尔生物：第二季度公司利润预计同比大幅增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2642144480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642144480?lang=zh_cn&edition=full","pubTime":"2026-06-10 16:55","pubTimestamp":1781081709,"startTime":"0","endTime":"0","summary":"针对近期股价大幅下挫、引发市场关注的情况，海尔生物日前在投资者互动平台作出回应，明确表示公司生产经营一切正常，不存在应披露而未披露的重大不利因素。利润方面，第二季度利润预计同比大幅增长，上半年利润端将出现拐点，下半年利润增幅有望进一步高于上半年，全力兑现“利润端在2026年迎来拐点”的指引。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026061000029742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783086525609,"stockEarnings":[{"period":"1week","weight":0.063},{"period":"1month","weight":-0.1223},{"period":"3month","weight":-0.1287},{"period":"6month","weight":-0.1455},{"period":"1year","weight":-0.116},{"period":"ytd","weight":-0.1455}],"compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.0113},{"period":"3month","weight":0.0384},{"period":"6month","weight":0.0151},{"period":"1year","weight":0.1662},{"period":"ytd","weight":0.0151}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"青岛海尔生物医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"14379人(较上一季度增加0.77%)","perCapita":"22010股","listingDate":"2019-10-25","address":"山东省青岛市城阳区高新区丰源路280号","registeredCapital":"31649万元","survey":" 青岛海尔生物医疗股份有限公司的主营业务是针对样本、药品、疫苗、血液等生物对象，提供涵盖-196°C至8°C全温域、软硬服一体化的生物安全解决方案。公司的主要产品是智慧实验室制药工艺、数字医院、智慧公共卫生、智慧用血。报告期内，公司低温存储技术持续领先，依托制冷平台，通过持续优化制冷系统设计、温湿控制和节能技术等核心模块，在极致稳定、绿色效能方向上构筑起代际领先优势。","listedPrice":15.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海尔生物,688139,海尔生物股票,海尔生物股票老虎,海尔生物股票老虎国际,海尔生物行情,海尔生物股票行情,海尔生物股价,海尔生物股市,海尔生物股票价格,海尔生物股票交易,海尔生物股票购买,海尔生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}